Changes in sex hormone‐binding globulin and testosterone during weight loss and weight maintenance in abdominally obese men with the metabolic syndrome
- 31 March 2004
- journal article
- Published by Wiley in Diabetes, Obesity and Metabolism
- Vol. 6 (3) , 208-215
- https://doi.org/10.1111/j.1462-8902.2004.00335.x
Abstract
Background: Mild hypoandrogenism in men, usually defined by low levels of testosterone, is a peculiar feature of abdominal obesity that independently predicts the development of insulin resistance and diabetes mellitus. Little is known about the short- and long-term effects of weight loss on sex steroids in abdominally obese men, however. Objectives: We assessed the effect of rapid weight loss and sustained weight maintenance on the plasma concentrations of testosterone and other sex hormones in 58 abdominally obese men (age, 46.3 ± 7.5 years; body mass index, 36.1 ± 3.8 kg/m2; waist girth, 121 ± 10 cm) with the metabolic syndrome. Results: The men lost on average 16.3 ± 4.5 kg during a 9-week very low-calorie diet (VLCD) and maintained 14.3 ± 9.1 kg weight loss after a 12-month maintenance period (vs. baseline, p < 0.001). Sex hormone-binding globulin (SHBG) increased from 27.6 ± 11.9 to 48.1 ± 23.5 nmol/l during the VLCD but decreased to 32.6 ± 12.9 nmol/l during weight maintenance, which was still higher than at baseline (p < 0.001). Free testosterone (fT) increased from 185 ± 66 to 208 ± 70 pmol/l (p = 0.002) during the VLCD and remained high after 1 year of weight maintenance (212 ± 84 pmol/l, p = 0.002). Total testosterone levels followed a pattern intermediate between fT and SHBG. Plasma estradiol and dehydroepiandrosterone sulphate concentrations changed only transiently or not at all. Conclusions: Rapid weight loss with successful weight maintenance in abdominally obese men with the metabolic syndrome brings about a sustained increase in fT levels. The dramatic increase in SHBG attenuated initially during weight maintenance but remained elevated. These findings may be important with regard to prevention of progressive metabolic decompensation and cardiovascular disease associated with obesity and the metabolic syndrome.Keywords
This publication has 39 references indexed in Scilit:
- Effect of estrogen deficiency in the male: the ArKO mouse modelMolecular and Cellular Endocrinology, 2002
- Sex steroids and insulin resistanceClinical Science, 2002
- Male andropause: myth, reality, and treatmentInternational Journal Of Impotence Research, 2002
- Thiazolidinediones Influence Plasma Steroids of Male Obese Zucker RatsEndocrinology, 2002
- A Transgenic Model of Visceral Obesity and the Metabolic SyndromeScience, 2001
- Executive Summary of the Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III)JAMA, 2001
- Steroid metabolism in Metabolic Syndrome XBest Practice & Research Clinical Endocrinology & Metabolism, 2001
- Tissue-Specific Dysregulation of Cortisol Metabolism in Human ObesityJournal of Clinical Endocrinology & Metabolism, 2001
- Type 1 11β-Hydroxysteroid Dehydrogenase Mediates Glucocorticoid Activation and Insulin Release in Pancreatic IsletsJournal of Biological Chemistry, 2000
- TrueInternational Journal of Obesity, 2000